False Claims Act Whistleblower Recovers More than $2.5M in Damages in Retaliation Case

In November 2019, Danita Erickson, a former sales representative at Biogen, prevailed at trial on her claims that Biogen terminated her employment in retaliation for her internal whistleblowing about the off-label promotion of a drug for a use outside the FDA-approved labeling.